RCMI Coordinating Center (RCMI CC) Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.
PropertyValue
has major subject area list Anemia, Sickle Cell; Antisickling Agents; Benzaldehydes; Hemoglobin, Sickle; Hemoglobins; Pyrazines; Pyrazoles
information resource reference Vichinsky E, Hoppe CC, Ataga KI, Ware RE, Nduba V, El-Beshlawy A, Hassab H, Achebe MM, Alkindi S, Brown RC, Diuguid DL, Telfer P, Tsitsikas DA, Elghandour A, Gordeuk VR, Kanter J, Abboud MR, Lehrer-Graiwer J, Tonda M, Intondi A, Tong B, Howard J. A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease. N Engl J Med. 2019 08 08; 381(6):509-519.
label A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.
Search Criteria
  • sickle cell disease
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support